HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export business. It has established a "1+2+3+4=1" service system and can supply L-selenomethionine sourced directly from multiple well-known original manufacturers. As a tech-driven foreign trade enterprise, HiSiaddi has conducted multiple rounds of factory inspections of L-selenomethionine manufacturers through technical transformation cooperation with factories, accumulating objective and in-depth insights into different manufacturers, and regularly providing clients with analysis of L-selenomethionine brands and factories to help them select matching products. Below is a brand selection service case.
Contact HiSiaddi customer service for more brand and model comparison analysis.
The buyer is VITABIO GmbH, a nutrition group headquartered in Heidelberg, Germany. For 27 years, it has specialized in developing and manufacturing premium over-the-counter dietary supplements for German-speaking regions, thyroid specialist nutrition tablets, and pregnancy & lactation organic selenium softgels. Its products are sold in federal German pharmacy chains, premium Austrian organic supermarkets and Swiss wellness clinics. All raw materials comply with EP, USP Pharmacopoeia, EU EFSA safety certifications, REACH registration, dual KOSHER & HALAL certifications, Non-GMO control, and clean label formulations rejecting low-quality chemically synthesized selenium raw materials. For over a decade, the group sourced L-selenomethionine exclusively from major German fine chemical manufacturers with an annual stable procurement volume of 26 tons.
Due to EU domestic chemical production restrictions, continuous raw material cost surges, raised minimum order quantities from original suppliers and extended sea freight lead times, the group’s procurement department launched a China supply chain traceability and selection project in 2025, planning to identify 1–2 long-term strategic domestic raw material manufacturers to partially replace original European imported supply.
The client initially independently contacted five leading domestic L-selenomethionine manufacturers: Zhejiang Novi Biotechnology, Shandong Lurui Biochemical, Anhui Xitai Biotechnology, Jiangsu Youkang Raw Materials, and Wuhan Pustar Biotechnology. During factory site visits, sample requests and quotation collection, the group encountered common industry barriers: all five manufacturers operated in compliance without maliciously slandering competitors, yet sales teams only promoted their own product advantages, constrained by corporate business orientation and performance assessments. They avoided objective comparison of competitors’ strengths, weaknesses and applicable scenarios, failing to disclose differentiated specifications of rival products. Unfamiliar with domestic raw material process grading, brand positioning and model classification standards, the German procurement team could not distinguish differences in indicators between feed-grade, general food-grade and pharmaceutical medical nutrition-grade products. Physical and chemical indicators of 8 sample batches submitted by the five manufacturers varied widely in powder flowability, impurity content and hygroscopicity. The client’s in-house R&D laboratory conducted formulation trials for 21 consecutive days, with multiple raw material batches triggering moisture absorption and caking when mixed with tablet and softgel excipients, alongside excessive selenium content attenuation in finished products over shelf life. Wasted R&D consumables and scrapped auxiliary materials incurred losses exceeding EUR 68,000, stalling the brand selection process. VITABIO GmbH formally entrusted HiSiaddi to fully oversee domestic brand horizontal evaluation, model screening, parameter benchmarking and sample trial coordination for end-to-end selection services, with core requirements to conduct a full horizontal breakdown of mainstream product lines across five brands, select 2 mid-to-high-end source manufacturers and 3 product models compatible with its medical nutrition formulations, and finalize a long-term annual supply agreement.
Mandatory Raw Material Benchmarks for Mid-to-High-End Medical Nutrition (Far Exceed General National Standard Raw Materials): Dry basis L-selenomethionine content ≥99.3%, inorganic selenium residue ≤0.2mg/kg, total organic impurities ≤0.15%, moisture ≤0.6%, angle of repose 27°~30%, compatible with fully automatic high-speed tableting and low-temperature softgel filling production. Raw materials must be manufactured via biofermentation processes with EU-recognized process traceability documents available.
HiSiaddi set up a special selection team of raw material physical and chemical engineers, EU compliance specialists and formulation application researchers. The team conducted on-site verification of GMP production workshops, quality inspection laboratories and historical SGS test archives at each factory. Combined with factory sample submissions, factory COA quality inspection certificates and end-application cases, the team broke away from one-sided promotional claims from individual manufacturers to conduct neutral horizontal evaluation of the five brands and their mainstream models, categorizing products into three tiers: high-end medical nutrition grade, mid-range general food grade and economical feed grade, and systematically sorting out the strengths and inherent limitations of each brand’s products.
Three core mass-produced models: NV-995 Refined Medical Nutrition Grade, NV-992 General Food Grade, NV-988 Economical Feed Additive Grade Advantages: Full production lines adopt microbial biofermentation processes with self-owned Class 100,000 GMP clean workshops and supporting three-stage high-precision chromatographic purification equipment. The NV-995 model internal control total impurities ≤0.11%, with powder modified via gradient temperature-controlled crystallization for a stable angle of repose around 28°, moisture controlled between 0.4%~0.55%, and batch uniformity RSD <1.7%. It has long supplied leading domestic medical nutrition enterprises and exported premium European brands with complete supporting certifications (FDA GRAS, REACH pre-registration, KOSHER certification), supporting minor customization of physical property parameters for small batches. Shortcomings: The premium NV-995 model carries a price premium of 18%~22% over general market products; NV-992 and NV-988 target mass-market health supplements and feed markets with crude powder sieving resulting in high fine powder ratios and weak flowability, incompatible with high-speed automatic tableting operations. The factory’s high-end production lines operate at full capacity year-round with a 7–10 day lead time for small-batch sample trial scheduling.
Two core models: LR-990 Food Grade, LR-975 Feed Grade Advantages: Annual L-selenomethionine output reaches 120 tons with prominent cost advantages from large-scale mass production, sufficient spot inventory and fast delivery. All national standard testing indicators pass inspection, compatible with general domestic tablet and powder health supplement production with affordable quotations, widely purchased by domestic supermarket health supplement brands. Standard orders can be shipped within 3 days. Shortcomings: Half of the core production lines adopt semi-chemical synthesis processes, failing to meet EU clean label requirements mandating fermentation sources for the client; raw materials only undergo two-stage resin purification with total impurities generally ranging from 0.25%~0.32%, high powder hygroscopicity with moisture absorption gain exceeding 1.5% after 72 hours under RH50% environment. Incorporation into low-temperature softgel formulations easily triggers crystal separation of contents, failing to meet Germany’s 24-month shelf-life standard.
Core models: XT-985 General Food Grade, XT-970 Livestock Special Grade Advantages: The lowest raw material unit price among the five manufacturers with low minimum order thresholds (small batches of 10kg available), stable purchasers including small and medium domestic health supplement factories and livestock feed enterprises with flexible supply terms. Shortcomings: No independent deep impurity removal sections, with fluctuating inorganic selenium residue levels and inconsistent batch stability. Solvent residues in partial batches approach national standard limit values. No complete EU market access certifications, unable to issue REACH or TSE animal-free statements, incompatible with German medical nutrition product compliance requirements.
Single core model: YK-972 Feed-Grade Selenomethionine Advantages: Deeply engaged in livestock feed raw materials with outstanding cost performance, designated supplier for major domestic feed groups with large-scale mass production capacity. Shortcomings: All products are positioned as feed-grade with maximum purity of only 97.2% and loose impurity control standards. No food and pharmaceutical-grade production lines have been established, with irregular powder particle sizes and severe static electricity, unsuitable for human dietary supplement production.
Two core models: PSD-993 Refined Food Grade, PSD-989 General Health Supplement Grade Advantages: Operates a small flexible pilot workshop enabling flexible fine-tuning of crystallization and drying parameters with fast small-batch sample response (3–5 days sample delivery). The PSD-993 model adopts full biofermentation processes with purity reaching 99.3% and impurity indicators approaching high-end standards, priced 8%~10% lower than Zhejiang Novi’s NV-995 model. Complete supporting documents are available, with bilingual Chinese-English quality inspection reports issued per EU standards. Shortcomings: Limited factory mass production capacity with an annual output of only 25 tons, weaker long-term large-batch supply stability compared to Zhejiang Novi. The PSD-989 model powder lacks modification treatment with an angle of repose above 35°, insufficient flowability incompatible with high-speed tableting production lines.
Combining VITABIO GmbH’s dual production lines of medical nutrition tablets and low-temperature softgels, strict EU compliance standards and stable annual procurement volume of 26 tons, Lurui, Xitai and Youkang were eliminated for failing to meet process and indicator requirements. Two mid-to-high-end suppliers — Zhejiang Novi Biotechnology and Wuhan Pustar Biotechnology — were finalized, with three matching models selected and tiered for core mass production, backup supplementary supply and small-batch new product testing to match different client product lines.
Selected Model 1: NV-995 Refined Medical Nutrition Grade (Core Mainstream Model) All indicators fully align with the client’s internal control standards: L-selenomethionine content 99.42%, total impurities 0.10%, moisture 0.48%, angle of repose 28.1°, full biofermentation process, complete EU compliance certification portfolio, perfectly compatible with the group’s high-speed thyroid support tablet production lines. Reliable large-factory stable capacity undertakes the core annual order of 19.5 tons scheduled in monthly staggered batches, with SGS full-test reports attached to every batch.
Selected Model 2: Optimized Customized NV-992 (Mass Production Backup Model) The original standard NV-992 general model was optimized via coordinated factory powder classified sieving and drying parameter fine-tuning, reducing moisture to 0.58%. It serves as a backup supply when NV-995 production capacity is tight, used for general multi-vitamin tablet production with lower procurement unit prices to optimize the client’s overall raw material costs.
Selected Model 3: PSD-993 Refined Food Grade (Special Model for New Infant Liquid Drops) Raw material purity reaches 99.35% with full biofermentation production routes. Its pilot workshop can fine-tune powder fineness to ultra-fine 120-mesh specifications on demand, compatible with the group’s new infant liquid selenium drop formulations for flexible small-batch separate shipments. The annual 6.5-ton procurement order is split for quarterly delivery, resolving bottlenecks of tight scheduling and high small-batch trial production costs for Novi’s high-end production lines.
HiSiaddi coordinated simultaneous sample delivery of the three qualified models from the two selected manufacturers, with unified submission to VITABIO GmbH’s R&D laboratory in Germany for 60-day formulation pilot trials and accelerated stability testing:
1. The NV-995 model was deployed for mass production of thyroid support tablets with no material blockage during high-speed tableting, tablet weight RSD ≤1.4%, no oxidative yellow discoloration or unpleasant tablet odors, and selenium attenuation of only 2.1% over 6 months of 40°C accelerated testing, meeting the 24-month shelf-life standard;
2. The ultra-fine PSD-993 specification raw material was applied to infant liquid drops with no crystal separation in low-temperature oil-soluble systems, remaining fully clear after 90 days of refrigerated storage;
3. The optimized NV-992 backup model was used for general multi-vitamin tablets, cutting overall procurement costs by 24% compared with original European imported raw materials.
All three sample batches passed full client acceptance, and a framework annual procurement contract for 26 tons was formally signed between both parties. The first 5.8 tons of raw materials were shipped in two containers from Ningbo Port to Hamburg Port, Germany. Complete COA reports, certificates of origin and REACH documents passed one-time inspection by German customs and the client’s incoming quality control, enabling delayed infant selenium drop new products to smoothly launch mass production.
1. VITABIO GmbH fully terminated cooperation with original German domestic suppliers, switching 100% of its L-selenomethionine supply to domestically sourced dual-brand raw materials coordinated by HiSiaddi. In the following year, customized ultra-high-purity specifications for sports nutrition powder were added, with an additional annual procurement volume of 7.5 tons;
2. Drawing on experience accumulated during this brand selection project, HiSiaddi assisted Novi and Pustar in optimizing standardized systems for export-grade products, sequentially developing two equivalent mid-to-high-end European nutrition brands in the Netherlands and Luxembourg;
3. The client designated HiSiaddi as its exclusive China raw material selection service provider, entrusting all subsequent brand screening and sample trial coordination for trace element raw materials including selenium yeast and zinc methionine to HiSiaddi.
The domestic L-selenomethionine market features distinct brand tiering with wide gaps in production processes, indicator standards and export compliance certifications between high-end medical nutrition grade, mid-range food grade and low-end feed-grade products. Restricted by sales-oriented business models, most manufacturers only promote their own products and avoid objective evaluation of competitors. Overseas mid-to-high-end medical nutrition purchasers lack familiarity with domestic industry grading standards and are easily misled by one-sided promotional claims from individual manufacturers during independent research, resulting in selection errors, scrapped formulations and delayed new product launches with economic losses. Traditional foreign trade only provides quotation matching services, while HiSiaddi operates as a neutral third-party technical service provider unbound by manufacturer interests. Centered on the client’s end-formulation production demands, it conducts horizontal objective evaluation of multiple brands’ strengths and weaknesses to screen tiered matching models. This solution enables overseas mid-to-high-end clients to accurately source cost-effective domestic raw materials and compress global supply chain costs, while helping high-quality domestic mid-to-high-end raw material manufacturers escape homogeneous low-price competition and access high-value EU medical nutrition raw material supply chains, delivering long-term win-win outcomes for both suppliers and buyers.
Contact HiSiaddi customer service for more brand and model comparison analysis.
+86-13120989737 
info@hisiaddi.com 
English
